Attorneys for Purdue Pharma and parties favoring its $4.3 billion bankruptcy settlement on Friday urged the U.S. Court of Appeals for the Second Circuit to reverse the district court’s ruling vacating the deal, arguing that the liability release for the Sackler family were appropriate and well-tailored.

U.S. District Judge Colleen McMahon of the Southern District of New York vacated the settlement in December, finding that the liability release was not authorized by the U.S. Bankruptcy Code. The case was briefed in the Second Circuit on an expedited basis.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]